Avadel Pharmaceuticals PLC (AVDL) on Thursday reported a loss of $27.5 million in its fourth quarter
DUBLIN (AP) — DUBLIN (AP) — Avadel Pharmaceuticals PLC (AVDL) on Thursday reported a loss of $27.5 million in its fourth quarter.
On a per-share basis, the Dublin-based company said it had a loss of 44 cents.
The results missed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 30 cents per share.
For the year, the company reported that its loss widened to $137.5 million, or $2.29 per share.
Avadel shares have increased 24% since the beginning of the year. The stock has risen 27% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a AVDL">Zacks stock report on AVDL at https://www.zacks.com/ap/AVDL